Feed AQSZF
AQ

Aequus Pharmaceuticals Inc.

AQSZF · OTC

$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $130.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.14x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining
Rev. growth 40.07%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak
Net margin 71.46%
Op. margin 62.50%
FCF margin 12.61%
Quality
79 /100
Excellent
ROA 334.60%
Asset turnover 4.68x
ROIC 22.38%
Debt
0 /100
High
Int. coverage -1.99x
Current ratio 0.03x
Net debt/EBITDA N/A
Stability
23 /100
Unstable
Rev. volatility 113.49%
EPS volatility 52.84%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o AQSZF
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Douglas Glen Janzen

Employees

12

Headquarters

Vancouver

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.